Target intelligence / Profile preview

microRNA 4691 (MIR4691)

Target
MIR4691
Molecular classification
Other (microRNA, non-protein coding RNA)
01

Overview

MicroRNA 4691 (MIR4691) is a human microRNA; a single-stranded, non-protein coding RNA of approximately 19–25 nucleotides in length. MicroRNAs bind to complementary sequences in the 3′ untranslated regions (UTRs) of target mRNAs and repress their translation or cause degradation. Specifically, miR-4691-3p has been shown to participate in the regulation of inflammation in human dental pulp by directly targeting the STING protein, thereby inhibiting the cGAS-STING innate immune pathway and downstream cytokine production such as IFN-β, TNF, and IL-6. There are no known transcripts produced from the MIR4691 gene itself, consistent with typical microRNA gene function, and its roles are achieved through post-transcriptional gene silencing. In research settings, synthetic inhibitors and agomirs are available to suppress or mimic miR-4691-3p, facilitating functional studies of its biological impact. There are currently no approved drugs directly targeting MIR4691 in clinical practice.

Other names
hsa-mir-4691mir-4691hsa-miR-4691-3phsa-miR-4691-5p
02

Mechanism of action

Antisense inhibition of the mature miRNA (for the inhibitor); Mimicry or overexpression of the miRNA function (for the agomir/miRNA mimics)

03

Biological functions

Regulation of gene expressionPost-transcriptional repressionInflammatory response modulationNegative regulation of the cGAS-STING signaling pathway
04

Disease associations

InflammationPossible roles in cancer and EMT (by analogy with other miRNAs, but no direct evidence located for MIR4691 specifically in cancer)
05

Safety considerations

Potential off-target gene regulation when using synthetic miRNA mimics or inhibitors
06

Interacting drugs

hsa-miR-4691-3p inhibitor (research chemical)

1 more in the full profile.

07

Biomarkers

Expression of miR-4691-3p in dental pulp tissue could serve as a biomarker for irreversible pulpitis

Beyond the preview

Go deeper on microRNA 4691 (MIR4691).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 4691 (MIR4691).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call